Literature DB >> 9207451

Short- and long-term multilineage repopulating hematopoietic stem cells in late fetal and newborn mice: models for human umbilical cord blood.

D E Harrison1, C M Astle.   

Abstract

Blood from late fetal and newborn mice is similar to umbilical cord blood obtained at birth in human beings, an important source of stem cells for clinical transplantation. The mouse model is useful because long-term functions can be readily assayed in vivo. To evaluate the functions of hematopoietic precursors in the blood and other tissues of late fetal and newborn mice, short- and long-term multilineage repopulating abilities were measured in vivo by competitive repopulation. Manipulations that might affect cell function, such as enrichment, tissue culture, or retroviral marking, were avoided. Hematopoietic stem cell functions of late fetal or newborn blood, liver, and spleen, were assayed as myeloid and lymphoid repopulating abilities relative to standard adult marrow cells. Donor cells from these tissues as well as adult control donor marrow cells were all of the same genotype. Cells from each donor tissue were mixed with portions from a pool of standard adult "competitor" marrow distinguished from the donors by genetic differences in hemoglobin and glucosephosphate isomerase. After 21 to 413 days, percentages of donor type myeloid and lymphoid cells in recipient blood were measured to assay the functional abilities of donor precursors relative to the standard. These relative measures are expressed as repopulating units, where each unit is equivalent to the repopulating ability found in 100,000 standard adult marrow cells. Thus, measures of repopulating units do not compare single cells but overall repopulating abilities of donor cell populations. Relative functional abilities in 1 million nucleated cells from late fetal or newborn blood were several times less than those found in adult marrow, but far more than in normal adult blood, and appeared to include long-term functional primitive hematopoietic stem cells (PHSC) similar to those in marrow. To estimate functional abilities of individual PHSC, variances among large groups of identical recipients were analyzed using both the binomial model and competitive dilution, a new model based on the Poisson distribution. The data best fit the hypothesis that individual PHSC from adult marrow, late fetal blood, or newborn blood each produce similar fractions of the total lymphoid and erythroid cells found in the recipient for many months.

Entities:  

Mesh:

Year:  1997        PMID: 9207451

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Global loss of leucine carboxyl methyltransferase-1 causes severe defects in fetal liver hematopoiesis.

Authors:  Jocelyn A Lee; Zhengqi Wang; Danielle Sambo; Kevin D Bunting; David C Pallas
Journal:  J Biol Chem       Date:  2018-05-07       Impact factor: 5.157

2.  Regulation of hematopoietic stem cell aging in vivo by a distinct genetic element.

Authors:  Hartmut Geiger; Gabriela Rennebeck; Gary Van Zant
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

Review 3.  The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man.

Authors:  Daniel A Zlotoff; Benjamin A Schwarz; Avinash Bhandoola
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

Review 4.  Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications.

Authors:  Koen Van Besien; Hongtao Liu; Nitin Jain; Wendy Stock; Andrew Artz
Journal:  Biol Blood Marrow Transplant       Date:  2012-11-08       Impact factor: 5.742

5.  Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock.

Authors:  Charlie R Mantel; Heather A O'Leary; Brahmananda R Chitteti; XinXin Huang; Scott Cooper; Giao Hangoc; Nickolay Brustovetsky; Edward F Srour; Man Ryul Lee; Steven Messina-Graham; David M Haas; Nadia Falah; Reuben Kapur; Louis M Pelus; Nabeel Bardeesy; Julien Fitamant; Mircea Ivan; Kye-Seong Kim; Hal E Broxmeyer
Journal:  Cell       Date:  2015-06-11       Impact factor: 41.582

6.  Transfusion of nonobese diabetic mice with allogeneic newborn blood ameliorates autoimmune diabetes and modifies the expression of selected immune response genes.

Authors:  Sundararajan Jayaraman; Tejas Patel; Vasu Patel; Shahnaz Ajani; Rebecca Garza; Arathi Jayaraman; Sung Kwon; Rajvir Singh; Damiano Rondelli; Bellur S Prabhakar; Mark Holterman
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

7.  Ex vivo culture of Fancc-/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy.

Authors:  Xiaxin Li; Michelle M Le Beau; Samantha Ciccone; Feng-Chun Yang; Brian Freie; Shi Chen; Jin Yuan; Ping Hong; Attilio Orazi; Laura S Haneline; D Wade Clapp
Journal:  Blood       Date:  2005-01-11       Impact factor: 22.113

8.  CD166 regulates human and murine hematopoietic stem cells and the hematopoietic niche.

Authors:  Brahmananda Reddy Chitteti; Michihiro Kobayashi; Yinghua Cheng; Huajia Zhang; Bradley A Poteat; Hal E Broxmeyer; Louis M Pelus; Helmut Hanenberg; Amy Zollman; Malgorzata M Kamocka; Nadia Carlesso; Angelo A Cardoso; Melissa A Kacena; Edward F Srour
Journal:  Blood       Date:  2014-04-16       Impact factor: 22.113

9.  Tgif1 regulates quiescence and self-renewal of hematopoietic stem cells.

Authors:  Ling Yan; Bethany Womack; David Wotton; Yan Guo; Yu Shyr; Utpal Davé; Chun Li; Scott Hiebert; Stephen Brandt; Rizwan Hamid
Journal:  Mol Cell Biol       Date:  2013-10-07       Impact factor: 4.272

10.  MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells.

Authors:  Flor M Perez-Campo; Guilherme Costa; Michael Lie-A-Ling; Stefano Stifani; Valerie Kouskoff; Georges Lacaud
Journal:  Stem Cells       Date:  2014-06       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.